YPSOMED HOLDING AG CHF14.15 (REGD) financial statements, including revenue, expenses, profit, and loss
The total revenue of 0QLQ for the last semiannual is 293.07 M CHF, and it's 14.75% higher compared to the previous semiannual. The net income of H2 23 is 41.79 M CHF.